Animal NDC 86101-020-13 Praziquantel
Animal Product Information
Praziquantel Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Other
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Each Chewable Tablet contains 23 mg praziquantel.
Description
Praziquantel Tablets 23 mg Feline Cestocide are sized for easy oral administration to either adult cats or kittens. The tablets may be crumbled and mixed with the feed.
Indications
Praziquantel Tablets 23 mg Feline Cestocide are indicated for the removal of the following canine cestodes: Dipylidium caninum and Taenia,taeniaeformis.
Contraindications
There are no known contraindications to the use of praziquantel in cats.
Action
Praziquantel Tablets are absorbed, metabolized in the liver and excreted in the bile. Upon entering the digestive tract from the bile, cestocidal activity is exhibited.1
Following exposure to praziquantel, the tapeworm loses its ability to resist digestion by the mammalian host. Because of this, whole tapeworms, including the scolex, are very rarely passed after administration of praziquantel. In many instances only disintegrated and partially digested pieces of tapeworms will be seen in the stool. The majority of tapeworms killed are digested and are not found in the feces.
Use Directions
Praziquantel Tablets 23 mg Feline Cestocide may be administered directly per os or crumbled and mixed with the feed. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage because of their higher metabolic rate. The optimum dose for each individual animal will be achieved by utilizing the following dosage schedule:
| Cats and Kittens* | |
| 4 pound and under | ½ tablet |
| 5-11 pounds. | 1 tablet |
| Over 11 pounds | 1½ tablets |
*Not intended for use in kittens less than 6 weeks of age.
Fasting
The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED.
Retreatment
For those animals maintained on premises where reinfections are likely to occur, clients should be instructed in the steps necessary to prevent reinfection; otherwise, retreatment may be necessary. This is especially true in cases of Dipylidium caninum infections where reinfection is almost certain to occur if fleas are not removed from the animal and its environment.
Animal Safety
The safety index has been derived from controlled safety evaluations, clinical trials and prior approved use in foreign countries.
Dosages of 5 times the labeled rate at 14 day intervals to cats as young as 5½ weeks did not produce clinical signs of toxicity. No significant clinical chemistry, hematological, or histopathological changes occurred. Symptoms of gross overdosage include vomition, salivation, diarrhea and depression.
Pregnancy
Praziquantel tablets have been tested in breeding and pregnant dogs. No adverse effects were noted.
Adverse Reactions
One instance of diarrhea and one of salivation (1.5%) were reported during the field trials in which 135 cats were administered praziquantel tablets 23 feline cestocide.
Contact Information
Contact Felix Pharmaceuticals Private Limited at 1-833-571-1525. To report suspected adverse drug experiences, contact Felix Pharmaceuticals Private
Limited at 1-833-571-1525. For additional information about reporting adverse drug experiences for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae
To obtain a Safety Data Sheet(s), contact Felix Pharmaceuticals Private Limited at 1-833-571-1525.
Warning
Keep out of the reach of children. Not for human use.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
How Supplied
Bottle of 3, 50 and 150 scored tablets.
Each scored tablet contains 23 mg praziquantel.
NDC Number | Tablet Size | Tablets/Bottle |
86101-020-21 | 23 mg | 3 Tablets |
86101-020-50 | 23 mg | 50 Tablets |
86101-020-13 | 23 mg | 150 Tablets |
References
1Andrews, P. Pharmacokinetic Studies with Droncit® in Animals Using a Biological Assay. Veterinary Medical Review 2/76: 154-165.
Approved by FDA under ANADA # 200-834
Distributed by:
Felixvet Inc.,
1300 NW Briarcliff Parkway,
Suite 100, Kansas City, Missouri 64150
Made in India
Neutral Code No. MP/DRUGS/25/90/2020
Rev. November 2025
Package Label.Principal Display Panel
NDC 86101-020-21
Praziquantel Tablets
23 mg
Feline Cestocide
CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.
WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.
EACH TABLET CONTAINS: 23 mg praziquantel
3 Chewable Tablets
Approved by FDA under ANADA # 200-834
NDC 86101-020-50
Praziquantel Tablets
23 mg
Feline Cestocide
CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.
WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.
EACH TABLET CONTAINS: 23 mg praziquantel
50 Chewable Tablets
Approved by FDA under ANADA # 200-834
NDC 86101-020-13
Praziquantel Tablets
23 mg
Feline Cestocide
CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.
WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.
EACH TABLET CONTAINS: 23 mg praziquantel
150 Chewable Tablets
Approved by FDA under ANADA # 200-834
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.
